Ritholtz Wealth Management’s Genmab GMAB Stock Holding History

Ritholtz Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,869	Closed	-$314K	–	873
2024 Q3	$314K	Buy	+12,869	New	+$344K	0.01%	688

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ritholtz Wealth Management's GMAB Position: Q4 2024 in Review

Ritholtz Wealth Management sold out of Genmab (GMAB) in Q4 2024, closing a stake of 12,869 shares — an estimated $314K sold.

Ritholtz Wealth Management first reported a position in GMAB in Q3 2024 and held it in 1 quarter. The position peaked at $314K in Q3 2024. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

Ritholtz Wealth Management reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
Ritholtz Wealth Management sold 12,869 Genmab shares in Q4 2024, an estimated $314K.
Ritholtz Wealth Management first reported a position in Genmab in Q3 2024 and held it in 1 quarter.
Ritholtz Wealth Management's Genmab position peaked at $314K in Q3 2024.
228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Ritholtz Wealth Management's 13F filing for Q4 2024, filed 15 Jan 2025.